Clinical trial showcases regional WA's role in medical breakthrough

Western Australia is continuing to showcase its work in medical research and innovation with the first commercially sponsored clinical trial for regional Western Australia currently underway.

Through WA Country Health Service, work is underway with international oncology research company Eli Lilly and Company to deliver a clinical trial aimed at alleviating nausea for patients undergoing chemotherapy. 

The WACHS Clinical Trial Centre, in collaboration with clinicians in the Goldfields and Great Southern, is leading the research.

The YAAD clinical trial is a Phase 2, double-blind, placebo-controlled study evaluating the efficacy of a new medicine to treat chemotherapy-induced nausea and vomiting.

Participants in the trial are randomly assigned into two groups; one is prescribed the medicine, and the other is given a placebo. Both groups then receive their planned chemotherapy treatment and usual standard-of care antiemetic medicine.

Dedicated in-house laboratory spaces have been established at the Albany and Esperance Health Campuses to collect local samples while regional clinicians administer medication and monitor participant health.